Listen Now
Topics Covered
- Overview of Triple Negative Breast Cancer, in the Context of COVID-19
- New Research on TNBC Presented at the San Antonio Breast Cancer Symposium (SABCS)
- Triple Negative Breast Cancer-Specific Treatment Updates
- The Important Role of Surgery in the Treatment of TNBC
- Updates on Clinical Trials in Advancing Treatment Choices
- The Increasing Role of Diagnostic Testing in Informing Treatment Options
- Investigational New Therapies in Clinical Trials
- New Developments in the Management of Treatment Side Effects
- Communicating with the Health Care Team with Telehealth/Telemedicine Appointments
- Roadmap to Prepare for These Appointments
- Key Questions to Ask Your Health Care Team
- Questions for Our Panel of Experts
Our Panel of Experts

Generosa Grana, MD, FACP
Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO
Chief, Division of Breast Surgery, Director, Interdisciplinary Breast Program, Weill Cornell Medicine/NewYork-Presbyterian Hospital Network

Shaveta Vinayak, MD, MS
Assistant Professor, Division of Oncology, University of Washington, Assistant Member, Fred Hutchinson Cancer Research Center, Physician, Seattle Cancer Care Alliance

Hayley Dinerman, JD
Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation

Lauren Chatalian, MSW
Women & Children’s Program Manager, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on December 15, 2020.